TGF‐β secreted by MSCs in osteosarcoma can increase the migratory capacity of tumor cells, which, in turn, stimulate the secretion of IL‐6 that fosters cancer cell stemness and aggressiveness 204, 205. Here, IL6 is linked to cancer.